World Federation of Nuclear Medicine and Biology
Disclaimer:
Information regarding a non-State actor, contained in the section “Non-State Actors Profiles”
in the Register, has been provided by that non-State actor itself, and the accuracy
and completeness of such information is the sole responsibility of that non-State
actor, not WHO. In turn, information in the sections “WHO’s Engagement” and “Non-State
Actors in Official Relations” has been provided by WHO, subject to certain conditions.
All access and use of any section of the Register is governed by the Terms and Conditions of Use.
Overview
World Federation of Nuclear Medicine and Biology
WFNMB
The World Federation of Nuclear Medicine and Biology (WFNMB) is the global umbrella organisation for Nuclear Medicine, Hybrid Imaging and Biology. One of WFNMB’s principal activities is, to support education efforts for nuclear physicians, physicists, radio-pharmacists, radiochemists, technologists and other nuclear medicine scientists, especially from the developing world.
www.wfnmb.org
20 Sep 2021 04:26:35 PM
General information
World Federation of Nuclear Medicine and Biology
WFNMB
World Federation of Nuclear Medicine and Biology
The World Federation of Nuclear Medicine and Biology (WFNMB) is the global umbrella organisation for Nuclear Medicine, Hybrid Imaging and Biology. One of WFNMB’s principal activities is, to support education efforts for nuclear physicians, physicists, radio-pharmacists, radiochemists, technologists and other nuclear medicine scientists, especially from the developing world.
Schmalzhofgasse 26, 5.OG
c/o EANM Office
Vienna
1060
Austria
office@wfnmb.org
www.wfnmb.org
Governance
In Austria registered non-profit Association (since 2011)
1970
Executive Board
Jean-Luc Urbain
President
Wake Forest Baptist Medical Center, Winston-Salem, NC, USA
Patricia Bernal
Secretary
Universidad Javeriana, Colombia
Savvas Frangos
Treasurer
Bank of Cyprus Oncology Centre, Cyprus
Lizette Louw
President Elect
CH Baragwanath Academic Hospital, Johannesburg, South Africa
Governance and representation of the Federation
Executive Board
Richard Wahl
SNMMI Representative
Mallinckrodt Institute of Radiology, St.Louis, United States of America
Jolanta Kunikowska
EANM Representative
Medical University Warsaw, Poland
Hee-Seung Bom
ARCCNM Representative
Chonnam National University Hwasun Hospital, Chonnam, South Korea
Gang Huang
AOFNMB Representative
Shanghai University of Medicine & Health Sciences(SUMHS), China
Fernando Faccio
ALASBIMN Representative
Sanatorio San Gerónimo, Santa Fe, Argentinia
Salah Eddine Bouyoucef
AANM Representative
CHU Babel Oued, Algiers, Algeria
Andrew Scott
ANZSNM Representative
Sir Charles Gairdner Hospital, Nedlands WA,Australia
Diana Paez
IAEA Representative
IAEA, Vienna, Austria
John Prior
WFNMB Representative to WHO
Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
Akram Al-Ibrahim
ARSNM Representative
King Hussein Cancer Center, Amman, Jordan
Dong Soo Lee
Past-President
Seoul National University, Korea
Delegate's Assembly
One delegate per member country in good standing, is allowed to attend the annual assembly, including the right to vote in the event of elections
(see also the official statues at http://www.wfnmb.org/?page_id=19)
• Receive the Annual Report of the President, Secretary General and Treasurer.
• Approve the nomination or deposition of members of the Executive Board and
auditors.
• Resolution on amendments of the Statutes.
• Fix the index for dues to be paid by member societies or groups.
• Grant exemption to the obligation to pay dues to any society or group which it
deems has shown due cause why such exemption should be granted.
• Approve the site for the Federation Executive Office.
• Approve and define subsidiary bodies. Subsidiary bodies shall be operational
bodies functioning under the Federation. The roles and administration of these
organs shall be specified in their rules and regulations.
• Resolution on the dissolution of the Federation.
• Voting for the site for the Federation Congress to be held six (6) years
subsequently. In the course of this election, the positions of the next Congress Chair, the Scientific Program Committee Chair as well as the Budget Committee Chair will be announced. Their office starts with January 1, two (2) years after the respective Assembly and lasts for four (4) years. The filling of the offices is part of the candidacies for the congress site of the Federation. The selection of the persons is not subject to of the vote of the General Assembly.
• Receive the Annual Report of the President, Secretary General and Treasurer.
• Approve the nomination or deposition of members of the Executive Board and
auditors.
• Resolution on amendments of the Statutes.
• Fix the index for dues to be paid by member societies or groups.
• Grant exemption to the obligation to pay dues to any society or group which it
deems has shown due cause why such exemption should be granted.
• Approve the site for the Federation Executive Office.
• Approve and define subsidiary bodies. Subsidiary bodies shall be operational
bodies functioning under the Federation. The roles and administration of these
organs shall be specified in their rules and regulations.
• Resolution on the dissolution of the Federation.
• Voting for the site for the Federation Congress to be held six (6) years
subsequently. In the course of this election, the positions of the next Congress Chair, the Scientific Program Committee Chair as well as the Budget Committee Chair will be announced. Their office starts with January 1, two (2) years after the respective Assembly and lasts for four (4) years. The filling of the offices is part of the candidacies for the congress site of the Federation. The selection of the persons is not subject to of the vote of the General Assembly.
Financial information
January
2020
December
2020
22,000
December
2020
230,000
Private sector entities (including business associations)
Philanthropic foundations
NGOs, academic institutions
Government entities, intergovernmental organizations, including
UN
General public, individuals
Total
22,000
22,000
22,000
22,000
Membership
Individuals
NGOs
44
44
Private sector entities
Philanthropic foundations
Academic institutions
Government entities
Intergovernmental organizations
https://www.wfnmb.org/countries
Organizational Structure
No data available
No data available
Relations
No data available
No data available
Activities
The Federation is a voluntary non-profit making organisation of societies/associations or groups associated for the following purposes
• To organise congresses, workshops and other educational activities covering all aspects of Nuclear Medicine and Biology
• To develop co-operation between societies/associations or groups active in Nuclear Medicine and Biology
• To promote the development of Nuclear Medicine and Biology
• To facilitate the exchange of scientists between the member societies/associations or
groups and to set up a body which will centralize and help such exchange
• To prepare and recommend the organization of a unified programme of teaching and
training in the field of Nuclear Medicine and Biology
• To establish technical standards, to aid in the diffusion of knowledge and exchange of
scientific and technical information by means of conferences, colloquia, symposia and
courses on regional, national and international levels
• To publish, alone or in collaboration, monographs, studies, teaching, courses, reports
from conferences, colloquia, symposia and congresses concerning Nuclear Medicine
and Biology
• To represent with one voice all Nuclear Medicine activities to the World Health
Organization, the International Atomic Energy Agency and other appropriate
organizations
• To organize whatever commissions and meetings are necessary to attain such
objectives
• To work with and support WFNMB subsidiary organizations and related organisations
to promote worldwide expansion of Nuclear Medicine and Biology
• To organise congresses, workshops and other educational activities covering all aspects of Nuclear Medicine and Biology
• To develop co-operation between societies/associations or groups active in Nuclear Medicine and Biology
• To promote the development of Nuclear Medicine and Biology
• To facilitate the exchange of scientists between the member societies/associations or
groups and to set up a body which will centralize and help such exchange
• To prepare and recommend the organization of a unified programme of teaching and
training in the field of Nuclear Medicine and Biology
• To establish technical standards, to aid in the diffusion of knowledge and exchange of
scientific and technical information by means of conferences, colloquia, symposia and
courses on regional, national and international levels
• To publish, alone or in collaboration, monographs, studies, teaching, courses, reports
from conferences, colloquia, symposia and congresses concerning Nuclear Medicine
and Biology
• To represent with one voice all Nuclear Medicine activities to the World Health
Organization, the International Atomic Energy Agency and other appropriate
organizations
• To organize whatever commissions and meetings are necessary to attain such
objectives
• To work with and support WFNMB subsidiary organizations and related organisations
to promote worldwide expansion of Nuclear Medicine and Biology
Strategic Priority 1: One billion more people benefiting from universal health coverage
Strategic Priority 2: One billion more people better protected from health emergencies
Strategic Priority 3: One billion more people enjoying better health and well-being
Strategic Priority 4: More effective and efficient WHO providing better support to countries
WFNMB organises every 4 years a world congress for Nuclear Medicine, Biology and related disciplines. The congress organisation as well as the finances involved, are handled by the Local Organising Bodies. WFNMB receives a minimum revenue of USD 50,000.- from the congress.
Country presence
Regions
Countries
Activities
Members
Offices / representatives
African Region
Region of the Americas
Eastern Mediterranean Region
European Region
South-East Asia Region
Western Pacific Region
Global
Disclosure & declaration
Pursuant the WHO Framework of Engagement with Non-State Actors, WHO does not engage with the tobacco industry or non-State actors that work to further the interests of the tobacco industry. WHO also does not engage with the arms industry.
For the purposes of this statement:
- tobacco industry means any entity involved in the manufacture, sale or distribution of tobacco and related products, and any affiliate of such entity; and
- arms industry means any entity involved in the manufacture, sale or distribution of arms, and any affiliate of such entity.
This disclosure statement needs to be provided by any nongovernmental organization, private sector entity, philanthropic foundation and academic institution prior to engaging with WHO.
In view of the foregoing, please answer the following questions:
- Is your entity, or was your entity
over the last four years, part of the tobacco or arms industries
(as defined above)?
- To the best of your entity’s knowledge,
is your entity, or has your entity over the last four years,
engaged in activities that are aimed at furthering or supporting
the interests of the tobacco industry? This includes, but is
not limited to, supply contracts, contract work, services and
lobbying.
- To the best of your entity’s knowledge,
does your entity currently, or did your entity over the last
four years, have any other association or relationship with the
tobacco industry (as defined above). This includes in particular
investment interests (other than general mutual funds or similar
arrangements whereby your entity has no control over the selection
of the investments), commercial business interests, the provision
or receipt of financial and/or other support.
- If you have answered yes to any of the above or are unable to answer one or more questions, please provide a general statement of explanation.
Please note that the WHO Secretariat reserves the right to request additional information from your entity in this regard.
By providing this statement, your entity commits to promptly inform WHO of any change to the above information and to complete a new statement that describes the changes.